삼성서울병원

Ko En

유방내분비외과 유종한 교수

진료분야
유방암, 유방암수술, 유방 악성 질환
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2016.02 서울대학교 대학원 의학 박사 졸업
2008.08 서울대학교 대학원 의학 석사 졸업
2000.02 서울대학교 의학과 졸업

경력

경력
2018.0301 ~현재 삼성서울병원 외과 전임대우 부교수
2017.0301 ~현재 삼성서울병원 유방암센터 간사
2015.10 ~ 2018.02 삼성서울병원 외과 진료부교수
2015.03 ~ 2015.09 서울아산병원 외과 임상부교수
2010.03 ~ 2015.02 서울아산병원 외과 임상조교수
2009.03 ~ 2010.02 서울대학교병원 외과 진료교수
2008.05 ~ 2009.02 서울대학교병원 외과 전임의
2001.03 ~ 2005.02 서울대학교병원 외과 레지던트 과정 수료
2000.03 ~ 2001.02 서울대학교병원 인턴과정 수료
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.342 Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance Kim1, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH
    View PubMed
  • ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169 Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0212309 Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011 A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • ONCOL REP 2019 10.3892/or.2018.6910 TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • ASIAN J SURG 2019 10.1016/j.asjsur.2018.06.004 Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice Lee1, SB; Yu, JH; Park, H; Kim, HJ; Park, SH; Chae, BJ; Youn, HJ; Jung, SY; Kim, EK; Jung, YS; Son, BH
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-018-5258-9 Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea Kim1, HK; Lee, SH; Kim, YJ; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Ahn, JS; Im, YH; Yu, JH; Park, YH
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ
    View PubMed
  • NUTRIENTS 2019 10.3390/nu11010037 Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
    View PubMed
  • HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3 The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e50 Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e54 Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003 Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004 Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010 Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
    View PubMed
  • ONCOLOGY-BASEL 2018 10.1159/000488944 Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • HEALTH QUAL LIFE OUT 2018 10.1186/s12955-018-0965-0 Uneven recovery patterns of compromised health-related quality of life (EQ-5D-3 L) domains for breast Cancer survivors: a comparative study Yu1, J; Son, WS; Lee, SB; Chung, IY; Son, BH; Ahn, SH; Jo, MW; Lee, JW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.206 Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.222 Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.173 Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4342-7 Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.91 Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.21 Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S
    View PubMed
  • CELL PHYSIOL BIOCHEM 2018 10.1159/000487171 Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002 Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003 Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5 Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22220 Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4398-y Radiation-related heart disease after breast cancer radiation therapy in Korean women Chang1, JS; Ko, BK; Bae, JW; Yu, JH; Park, MH; Jung, Y; Jeon, YW; Kim, KH; Shin, J; Suh, CO; Kim, YB
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22193 Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers Park1, B; Hopper, JL; Win, AK; Dowty, JG; Sung, HK; Ahn, C; Kim, SW; Lee, MH; Lee, J; Lee, JW; Kang, E; Yu, JH; Kim, KS; Moon, BI; Han, W; Noh, DY; Park, SK
    View PubMed
  • CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014 Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.528 Education Level Is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: A Study Based on the Nationwide Korean Breast Cancer Registry Database Hwang1, KT; Noh, W; Cho, SH; Yu, J; Park, MH; Jeong, J; Lee, HJ; Kim, J; Oh, S; Kim, YA
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.3.297 Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.203.270 Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24. Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24. Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.
    View PubMed
  • Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746. Conditional disease-free survival among patients with breast cancer Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.
    View PubMed
  • Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.
    View PubMed
  • Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.
    View PubMed